Spotlight on inhaled ciprofloxacin and its potential in the treatment of non-cystic fibrosis bronchiectasis
Stamatia Chorepsima,1,2 Konstantinos S Kechagias,1 Georgios Kalimeris,1,2 Nikolaos A Triarides,1,2 Matthew E Falagas1–3 1Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece; 2Department of Medicine, Henry Dunant Hospital Center, Athens, Greece; 3Department of Medicine, Tufts Unive...
Saved in:
Main Authors: | Chorepsima S (Author), Kechagias KS (Author), Kalimeris G (Author), Triarides NA (Author), Falagas ME (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin DA, et al.
Published: (2013) -
Review: Quality of Life in Children with Non-cystic Fibrosis Bronchiectasis
by: Anna Marie Nathan, et al.
Published: (2017) -
The Role of Macrolides in Childhood Non-Cystic Fibrosis-Related Bronchiectasis
by: R. Masekela, et al.
Published: (2012) -
Non-cystic fibrosis bronchiectasis in children and adolescents: Neglected and emerging issues
by: Marco Poeta, et al.
Published: (2020) -
Epidemiology and outcomes of multidrug-resistant bacterial infection in non-cystic fibrosis bronchiectasis
by: Chih-Hao Chang, et al.
Published: (2024)